These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 11699811)
1. Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. Greenhill LL; Pliszka S; Dulcan MK; Bernet W; Arnold V; Beitchman J; Benson RS; Bukstein O; Kinlan J; McClellan J; Rue D; Shaw JA; Stock S; Kroeger K J Am Acad Child Adolesc Psychiatry; 2001 Nov; 40(11):1352-5. PubMed ID: 11699811 [TBL] [Abstract][Full Text] [Related]
2. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. Greenhill LL; Pliszka S; Dulcan MK; Bernet W; Arnold V; Beitchman J; Benson RS; Bukstein O; Kinlan J; McClellan J; Rue D; Shaw JA; Stock S; J Am Acad Child Adolesc Psychiatry; 2002 Feb; 41(2 Suppl):26S-49S. PubMed ID: 11833633 [TBL] [Abstract][Full Text] [Related]
3. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder. Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962 [TBL] [Abstract][Full Text] [Related]
4. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications. Varley CK; Vincent J; Varley P; Calderon R Compr Psychiatry; 2001; 42(3):228-33. PubMed ID: 11349243 [TBL] [Abstract][Full Text] [Related]
5. Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder. Stevenson RD; Wolraich ML Pediatr Clin North Am; 1989 Oct; 36(5):1183-97. PubMed ID: 2677938 [TBL] [Abstract][Full Text] [Related]
6. Treatment of attention-deficit/hyperactivity disorder. Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990 [TBL] [Abstract][Full Text] [Related]
7. Stimulant medications in adults with attention deficit disorder. Gauthier M Can J Psychiatry; 1984 Aug; 29(5):435-40. PubMed ID: 6148139 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. Goldman LS; Genel M; Bezman RJ; Slanetz PJ JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570 [TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder. Lurie S; O'Quinn A J Neuropsychiatry Clin Neurosci; 1991; 3(1):41-50. PubMed ID: 7580171 [TBL] [Abstract][Full Text] [Related]
11. Is the evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder flawed? Hoekstra PJ; Buitelaar JK Eur Child Adolesc Psychiatry; 2016 Apr; 25(4):339-40. PubMed ID: 27021055 [No Abstract] [Full Text] [Related]
13. [Stimulant therapy in children]. Steinhausen HC Pharmacopsychiatria; 1982 Nov; 15(6):181-2. PubMed ID: 6130534 [No Abstract] [Full Text] [Related]
14. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder. Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858 [TBL] [Abstract][Full Text] [Related]
15. New stimulant formulations for pediatric attention-deficit/hyperactivity disorder: a case-based approach for the primary care provider. Partain PI; White J; Hammerness P Curr Opin Pediatr; 2019 Feb; 31(1):166-174. PubMed ID: 30531224 [TBL] [Abstract][Full Text] [Related]
16. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ; Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203 [TBL] [Abstract][Full Text] [Related]
18. Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder. Nolan EE; Gadow KD; Sprafkin J Pediatrics; 1999 Apr; 103(4 Pt 1):730-7. PubMed ID: 10103294 [TBL] [Abstract][Full Text] [Related]
19. Advances and considerations in attention-deficit/hyperactivity disorder pharmacotherapy. Mohammadi M; Akhondzadeh S Acta Med Iran; 2011; 49(8):487-98. PubMed ID: 22009816 [TBL] [Abstract][Full Text] [Related]
20. The Effects of Long-Acting Stimulant and Nonstimulant Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials. Cerrillo-Urbina AJ; García-Hermoso A; Pardo-Guijarro MJ; Sánchez-López M; Santos-Gómez JL; Martínez-Vizcaíno V J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):494-507. PubMed ID: 29897263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]